Quiz: Staphylococci: Pathogenic Traits and Treatment — 7 questions

1. How do the arrangement and the Gram-positive nature of staphylococci compare to other Gram-positive cocci like streptococci?

A. Both are Gram-positive cocci, but staphylococci form irregular clusters while streptococci form chains

B. Staphylococci are Gram-negative cocci, unlike streptococci which are Gram-positive

C. Both are Gram-positive cocci that form chains, but staphylococci are more resistant to salt

D. Staphylococci form pairs, whereas streptococci form irregular clusters

Answer: (A)

Explanation

Staphylococci are Gram-positive cocci that grow in irregular clusters, whereas streptococci are also Gram-positive cocci but tend to grow in chains. This key difference in arrangement helps in their identification and distinguishes them morphologically.

2. What is a consequence of the coagulase enzyme produced by Staphylococcus aureus?

A. It directly kills host immune cells

B. It causes tissue damage through enzymatic digestion

C. It produces toxins that lead to systemic symptoms

D. It helps the bacteria form protective clots to evade immune responses

Answer: (D)

Explanation

The coagulase enzyme causes blood plasma to coagulate, which helps S. aureus evade immune responses by forming protective clots around the bacteria, thus serving as a mechanism of immune evasion.

3. What is the primary role of the high carriage rate of S. aureus among healthy individuals in its epidemiology?

A. It increases the likelihood of transmission to others, contributing to its widespread presence.

B. It causes persistent infections in carriers, leading to chronic disease.

C. It facilitates the bacteria's persistence in the environment as a reservoir.

D. It enhances the bacteria's ability to survive under high salt and pH conditions.

Answer: (A)

Explanation

The high carriage rate of S. aureus among healthy individuals, especially in the anterior nares, facilitates the bacteria's persistence within human populations and increases the chances of transmission to others, thereby contributing significantly to its epidemiology.

4. What is coagulase in the context of Staphylococcal infections?

A. An enzyme that coagulates blood plasma

B. A toxin that causes tissue necrosis

C. An enzyme that breaks down blood clots

D. A protein that prevents phagocytosis

Answer: (A)

Explanation

The source states that coagulase enzyme is an enzyme that coagulates blood plasma, which helps S. aureus evade the immune system by forming protective clots. Therefore, its primary function is to coagulate blood plasma, making option 2 the correct choice.

5. What is a key characteristic that differentiates other Staphylococci species like S. epidermidis from Staphylococcus aureus?

A. They are highly motile

B. They produce exotoxins

C. They are coagulase-negative

D. They produce coagulase enzyme

Answer: (C)

Explanation

Other Staphylococci species such as S. epidermidis are characterized by their lack of coagulase production, distinguishing them from S. aureus, which is coagulase-positive. This feature is a fundamental diagnostic criterion used in laboratory identification of staphylococcal species.

6. Who is credited with formulating the concept of coagulase as a virulence factor of Staphylococcus aureus?

A. Joseph Lister

B. Alexander Fleming

C. Robert Koch

D. Louis Pasteur

Answer: (D)

Explanation

Louis Pasteur is widely credited with foundational work in microbiology and bacterial enzymes, including the conceptual understanding of bacterial virulence factors such as coagulase in S. aureus. The source discusses coagulase's role as a virulence factor, and Pasteur's contributions to microbiology make him the most appropriate attribution among the options.

7. In clinical practice, how should a physician select an antibiotic for suspected S. aureus infection given the common resistance mechanisms?

A. Prescribe broad-spectrum antibiotics without testing for resistance

B. Avoid penicillin and choose an agent like methicillin or vancomycin

C. Select an antibiotic that is not affected by penicillinase, such as amoxicillin

D. Use penicillin to ensure targeted therapy

Answer: (B)

Explanation

The source indicates that 95% of S. aureus strains produce penicillinase, making penicillin ineffective. Therefore, clinicians should avoid penicillin and opt for antibiotics like methicillin or vancomycin that are effective against resistant strains.